We are live on ! Find out more
ALNA

Allena Pharmaceuticals
ALNA

Delisted

ALNA was delisted on the 7th of September, 2022.

Back to rankings

Fund managers haven’t disclosed any holdings of ALNA yet.

ALNA Hedge Fund Activity: Q4 2022 in Review

0 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Allena Pharmaceuticals (ALNA) for Q4 2022, worth a combined $0 — down 100% from $4K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ALNA and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Acadian Asset Management, exiting entirely with an estimated $4K sold.

  • 0 institutional investors held Allena Pharmaceuticals (ALNA) as of Q4 2022, down from 2 in Q3 2022.
  • Funds reported $0 of Allena Pharmaceuticals stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Allena Pharmaceuticals positions in Q4 2022 and 2 closed out, a net change of -2 holders.
  • The largest Allena Pharmaceuticals seller in Q4 2022 was Acadian Asset Management, an estimated $4K sold.

Based on aggregated 13F filings for Q4 2022.